Characterization of a Designed Vascular Endothelial Growth Factor Receptor Antagonist Helical Peptide with Antiangiogenic Activity in Vivo-Reference-Cited by-同舟云学术

Characterization of a Designed Vascular Endothelial Growth Factor Receptor Antagonist Helical Peptide with Antiangiogenic Activity in Vivo

Published:2011-01-31 Issue:5 Volume:54 Page:1391-1400
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Basile Anna¹,Del Gatto Annarita²,Diana Donatella²,Di Stasi Rossella²,Falco Antonia¹,Festa Michelina¹,Rosati Alessandra¹,Barbieri Antonio³,Franco Renato³,Arra Claudio³,Pedone Carlo⁴,Fattorusso Roberto⁵,Turco Maria Caterina¹,D’Andrea Luca Domenico²

Affiliation:

1. Dipartimento di Scienze Farmaceutiche, Università di Salerno and BioUniverSA SRL, Salerno, Italy

2. Istituto di Biostrutture e Bioimmagini, CNR, Via Mezzocannone 16, 80134 Napoli, Italy

3. Istituto Nazionale Tumori “Fondazione G. Pascale”, Napoli, Italy

4. Dipartimento delle Scienze Biologiche, Università di Napoli “Federico II”, Napoli, Italy

5. Dipartimento di Scienze Ambientali, Seconda Università di Napoli, Caserta, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm101435r

Reference43 articles.

1. Angiogenesis in life, disease and medicine

2. Angiogenesis

3. Therapeutic angiogenesis in the heart: protect and serve

4. The biology of VEGF and its receptors

5. From angiogenesis to neuropathology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled 15-mer peptide internalization is mediated by megalin (LRP2 receptor) in a CRISPR/Cas9-based LRP2 knockout human kidney cell model;EJNMMI Radiopharmacy and Chemistry;2024-04-18

2. A TLR4‐Targeting Bioactive Peptide Hydrogel to Regulate Immune‐Microenvironment for Diabetic Wound Repair;Advanced Healthcare Materials;2024-04-11

3. Structure-Based Design of Peptides Targeting VEGF/VEGFRs;Pharmaceuticals;2023-06-07

4. RGD and Scutellarin Conjugate (WK001) Targeting Platelet Glycoprotein IIb/IIIa Receptor Protects from Myocardial Ischemia/Reperfusion Injury: Synthesis, Characterization, and Bioactivity Evaluation;Bioconjugate Chemistry;2023-02-06

5. Receptor tyrosine kinases (RTKs);Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders;2023